Click for best price
Breast Cancer Targeted Drug Market Size, Share 2023
Breast cancer?is a disease in which cells in the breast grow out of control. There are different kinds of?breast cancer.?
This report contains market size and forecasts of Breast Cancer Targeted Drug in Global, including the following market information:
Global Breast Cancer Targeted Drug Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Breast Cancer Targeted Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Brand Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Breast Cancer Targeted Drug include Eli Lilly and Company, Roche, Merck & Co., Novartis, Pfizer, Merck KGaA, Astellas, Janssen Biotech and Bristol-Myers Squibb, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Breast Cancer Targeted Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Targeted Drug Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Breast Cancer Targeted Drug Market Segment Percentages, by Type, 2022 (%)
Brand Drugs
Generic Drug
Global Breast Cancer Targeted Drug Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Breast Cancer Targeted Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Breast Cancer Targeted Drug Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Breast Cancer Targeted Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Breast Cancer Targeted Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Breast Cancer Targeted Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company
Roche
Merck & Co.
Novartis
Pfizer
Merck KGaA
Astellas
Janssen Biotech
Bristol-Myers Squibb
Gilead Sciences
| Report Attributes |
Report Details |
| Report Title |
Breast Cancer Targeted Drug Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Breast Cancer Targeted Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Breast Cancer Targeted Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Breast Cancer Targeted Drug Overall Market Size
2.1 Global Breast Cancer Targeted Drug Market Size: 2022 VS 2030
2.2 Global Breast Cancer Targeted Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Breast Cancer Targeted Drug Players in Global Market
3.2 Top Global Breast Cancer Targeted Drug Companies Ranked by Revenue
3.3 Global Breast Cancer Targeted Drug Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Targeted Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Breast Cancer Targeted Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Targeted Drug Players in Global Market
3.6.1 List of Global Tier 1 Breast Cancer Targeted Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Targeted Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Breast Cancer Targeted Drug Market Size Markets, 2022 & 2030
4.1.2 Brand Drugs
4.1.3 Generic Drug
4.2 By Type - Global Breast Cancer Targeted Drug Revenue & Forecasts
4.2.1 By Type - Global Breast Cancer Targeted Drug Revenue, 2018-2023
4.2.2 By Type - Global Breast Cancer Targeted Drug Revenue, 2023-2030
4.2.3 By Type - Global Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Breast Cancer Targeted Drug Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Breast Cancer Targeted Drug Revenue & Forecasts
5.2.1 By Application - Global Breast Cancer Targeted Drug Revenue, 2018-2023
5.2.2 By Application - Global Breast Cancer Targeted Drug Revenue, 2023-2030
5.2.3 By Application - Global Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Breast Cancer Targeted Drug Market Size, 2022 & 2030
6.2 By Region - Global Breast Cancer Targeted Drug Revenue & Forecasts
6.2.1 By Region - Global Breast Cancer Targeted Drug Revenue, 2018-2023
6.2.2 By Region - Global Breast Cancer Targeted Drug Revenue, 2023-2030
6.2.3 By Region - Global Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Breast Cancer Targeted Drug Revenue, 2018-2030
6.3.2 US Breast Cancer Targeted Drug Market Size, 2018-2030
6.3.3 Canada Breast Cancer Targeted Drug Market Size, 2018-2030
6.3.4 Mexico Breast Cancer Targeted Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Breast Cancer Targeted Drug Revenue, 2018-2030
6.4.2 Germany Breast Cancer Targeted Drug Market Size, 2018-2030
6.4.3 France Breast Cancer Targeted Drug Market Size, 2018-2030
6.4.4 U.K. Breast Cancer Targeted Drug Market Size, 2018-2030
6.4.5 Italy Breast Cancer Targeted Drug Market Size, 2018-2030
6.4.6 Russia Breast Cancer Targeted Drug Market Size, 2018-2030
6.4.7 Nordic Countries Breast Cancer Targeted Drug Market Size, 2018-2030
6.4.8 Benelux Breast Cancer Targeted Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Breast Cancer Targeted Drug Revenue, 2018-2030
6.5.2 China Breast Cancer Targeted Drug Market Size, 2018-2030
6.5.3 Japan Breast Cancer Targeted Drug Market Size, 2018-2030
6.5.4 South Korea Breast Cancer Targeted Drug Market Size, 2018-2030
6.5.5 Southeast Asia Breast Cancer Targeted Drug Market Size, 2018-2030
6.5.6 India Breast Cancer Targeted Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Breast Cancer Targeted Drug Revenue, 2018-2030
6.6.2 Brazil Breast Cancer Targeted Drug Market Size, 2018-2030
6.6.3 Argentina Breast Cancer Targeted Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Breast Cancer Targeted Drug Revenue, 2018-2030
6.7.2 Turkey Breast Cancer Targeted Drug Market Size, 2018-2030
6.7.3 Israel Breast Cancer Targeted Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Breast Cancer Targeted Drug Market Size, 2018-2030
6.7.5 UAE Breast Cancer Targeted Drug Market Size, 2018-2030
7 Players Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporate Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Breast Cancer Targeted Drug Major Product Offerings
7.1.4 Eli Lilly and Company Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly and Company Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Breast Cancer Targeted Drug Major Product Offerings
7.2.4 Roche Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.2.5 Roche Key News
7.3 Merck & Co.
7.3.1 Merck & Co. Corporate Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Breast Cancer Targeted Drug Major Product Offerings
7.3.4 Merck & Co. Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.3.5 Merck & Co. Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Breast Cancer Targeted Drug Major Product Offerings
7.4.4 Novartis Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Breast Cancer Targeted Drug Major Product Offerings
7.5.4 Pfizer Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News
7.6 Merck KGaA
7.6.1 Merck KGaA Corporate Summary
7.6.2 Merck KGaA Business Overview
7.6.3 Merck KGaA Breast Cancer Targeted Drug Major Product Offerings
7.6.4 Merck KGaA Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.6.5 Merck KGaA Key News
7.7 Astellas
7.7.1 Astellas Corporate Summary
7.7.2 Astellas Business Overview
7.7.3 Astellas Breast Cancer Targeted Drug Major Product Offerings
7.7.4 Astellas Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.7.5 Astellas Key News
7.8 Janssen Biotech
7.8.1 Janssen Biotech Corporate Summary
7.8.2 Janssen Biotech Business Overview
7.8.3 Janssen Biotech Breast Cancer Targeted Drug Major Product Offerings
7.8.4 Janssen Biotech Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.8.5 Janssen Biotech Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Breast Cancer Targeted Drug Major Product Offerings
7.9.4 Bristol-Myers Squibb Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News
7.10 Gilead Sciences
7.10.1 Gilead Sciences Corporate Summary
7.10.2 Gilead Sciences Business Overview
7.10.3 Gilead Sciences Breast Cancer Targeted Drug Major Product Offerings
7.10.4 Gilead Sciences Breast Cancer Targeted Drug Revenue in Global Market (2018-2023)
7.10.5 Gilead Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Breast Cancer Targeted Drug Market Opportunities & Trends in Global Market
Table 2. Breast Cancer Targeted Drug Market Drivers in Global Market
Table 3. Breast Cancer Targeted Drug Market Restraints in Global Market
Table 4. Key Players of Breast Cancer Targeted Drug in Global Market
Table 5. Top Breast Cancer Targeted Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Breast Cancer Targeted Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Breast Cancer Targeted Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Breast Cancer Targeted Drug Product Type
Table 9. List of Global Tier 1 Breast Cancer Targeted Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Targeted Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Breast Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Breast Cancer Targeted Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Breast Cancer Targeted Drug Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Breast Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Breast Cancer Targeted Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Breast Cancer Targeted Drug Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Breast Cancer Targeted Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Breast Cancer Targeted Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Breast Cancer Targeted Drug Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Breast Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Breast Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Breast Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Breast Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Breast Cancer Targeted Drug Revenue, (US$, Mn), 2023-2030
Table 30. Eli Lilly and Company Corporate Summary
Table 31. Eli Lilly and Company Breast Cancer Targeted Drug Product Offerings
Table 32. Eli Lilly and Company Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 33. Roche Corporate Summary
Table 34. Roche Breast Cancer Targeted Drug Product Offerings
Table 35. Roche Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 36. Merck & Co. Corporate Summary
Table 37. Merck & Co. Breast Cancer Targeted Drug Product Offerings
Table 38. Merck & Co. Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 39. Novartis Corporate Summary
Table 40. Novartis Breast Cancer Targeted Drug Product Offerings
Table 41. Novartis Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Breast Cancer Targeted Drug Product Offerings
Table 44. Pfizer Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 45. Merck KGaA Corporate Summary
Table 46. Merck KGaA Breast Cancer Targeted Drug Product Offerings
Table 47. Merck KGaA Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 48. Astellas Corporate Summary
Table 49. Astellas Breast Cancer Targeted Drug Product Offerings
Table 50. Astellas Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 51. Janssen Biotech Corporate Summary
Table 52. Janssen Biotech Breast Cancer Targeted Drug Product Offerings
Table 53. Janssen Biotech Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Breast Cancer Targeted Drug Product Offerings
Table 56. Bristol-Myers Squibb Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
Table 57. Gilead Sciences Corporate Summary
Table 58. Gilead Sciences Breast Cancer Targeted Drug Product Offerings
Table 59. Gilead Sciences Breast Cancer Targeted Drug Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Breast Cancer Targeted Drug Segment by Type in 2022
Figure 2. Breast Cancer Targeted Drug Segment by Application in 2022
Figure 3. Global Breast Cancer Targeted Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Breast Cancer Targeted Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Breast Cancer Targeted Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Breast Cancer Targeted Drug Revenue in 2022
Figure 8. By Type - Global Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 10. By Region - Global Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 11. By Country - North America Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 12. US Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 16. Germany Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 17. France Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 24. China Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 28. India Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 30. Brazil Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Breast Cancer Targeted Drug Revenue Market Share, 2018-2030
Figure 33. Turkey Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Breast Cancer Targeted Drug Revenue, (US$, Mn), 2018-2030
Figure 37. Eli Lilly and Company Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Roche Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Merck & Co. Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Novartis Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Pfizer Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck KGaA Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Astellas Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Janssen Biotech Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bristol-Myers Squibb Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gilead Sciences Breast Cancer Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
